Log In
Print
BCIQ
Print
Print this Print this
 

Opicapone (ONO-2370) (formerly BIA 9-1067)

  Manage Alerts
Collapse Summary General Information
Company Bial-Portela & Ca. S.A.
DescriptionCatechol-O-methyl-transferase (COMT) inhibitor
Molecular Target Catechol-O-methyl-transferase (COMT)
Mechanism of ActionCatechol-O-methyl-transferase (COMT) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation EU - Standard Review (Treat Parkinson's disease (PD))
Partner Ono Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today